Forest Devices, Inc

Medtech · Private

A prehospital electrochemical impedance spectroscopy (EIS) device to detect hemorrhagic stroke in the field by measuring impedance across frequency spectra to differentiate hemorrhagic from ischemic s

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$224K
Federal grants
$224K
1 award · 2020
Rank in peer group#414 of 542
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
12
11 pending · first 2019
Rank in peer group#17 of 542

Capital timeline

2020FEDERAL ↑EQUITY ↓Cumulative $224K$224K
2020FEDERAL ↑EQUITY ↓Cumulative $224K$224K

Latest events

  • Federal grantNSF · Phase I · SBIR Phase I: Hemorrhagic Stroke Detection with Electrochemical Impedance Spectroscopy ;$224K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#17 · top 3%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Matthew KesingerResearcherExecutive Officer, DirectorLinked by 4 patents
  • Ashok RaoDirectorNamed in SEC Form D filings
  • Carmelo MontalvoExecutive OfficerNamed in SEC Form D filings
  • Daniel WillisExecutive OfficerNamed in SEC Form D filings
  • David MotleyDirectorNamed in SEC Form D filings
  • Giovanni MagniDirectorNamed in SEC Form D filings
Show all 10 people
  • Ian ColrainDirectorNamed in SEC Form D filings
  • Stephen MorrowExecutive OfficerNamed in SEC Form D filings
  • Steve FleckDirectorNamed in SEC Form D filings
  • Tom BumgardnerExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 12 granted of 23
Show all 23 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .